Recombinant multi-species MYH14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYH14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
The Alternative Names of target: 2400004E04Rik,DFNA4,DFNA4A,FP17425,II-C,MHC16,MYH14,MYH17,Myh14,Myosin heavy chain,Myosin heavy chain 14,Myosin-14,NHMCII,NMHC II-C,NMHC-II-C,Non-muscle myosin heavy chain IIc (NMHC II-C),PNMHH,myosin,non-muscle IIc

Target products collectionGo to MYH14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12280-Ag-1/ GM-Tg-hg-IP12280-Ag-2 Human MYH14 protein Human
GM-Tg-rg-IP12280-Ag-1/ GM-Tg-rg-IP12280-Ag-2 Rat MYH14 protein Rat
GM-Tg-mg-IP12280-Ag-1/ GM-Tg-mg-IP12280-Ag-2 Mouse MYH14 protein Mouse
GM-Tg-cynog-IP12280-Ag-1/ GM-Tg-cynog-IP12280-Ag-2 Cynomolgus/Rhesus macaque MYH14 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12280-Ag-1/ GM-Tg-felg-IP12280-Ag-2 Feline MYH14 protein Feline
GM-Tg-cang-IP12280-Ag-1/ GM-Tg-cang-IP12280-Ag-2 Canine MYH14 protein Canine
GM-Tg-bovg-IP12280-Ag-1/ GM-Tg-bovg-IP12280-Ag-2 Bovine MYH14 protein Bovine
GM-Tg-equg-IP12280-Ag-1/ GM-Tg-equg-IP12280-Ag-2 Equine MYH14 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12280-Ag-1/ GM-Tg-hg-IP12280-Ag-2; GM-Tg-rg-IP12280-Ag-1/ GM-Tg-rg-IP12280-Ag-2;
GM-Tg-mg-IP12280-Ag-1/ GM-Tg-mg-IP12280-Ag-2; GM-Tg-cynog-IP12280-Ag-1/ GM-Tg-cynog-IP12280-Ag-2;
GM-Tg-felg-IP12280-Ag-1/ GM-Tg-felg-IP12280-Ag-2; GM-Tg-cang-IP12280-Ag-1/ GM-Tg-cang-IP12280-Ag-2;
GM-Tg-bovg-IP12280-Ag-1/ GM-Tg-bovg-IP12280-Ag-2; GM-Tg-equg-IP12280-Ag-1/ GM-Tg-equg-IP12280-Ag-2
Products Name MYH14 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MYH14
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MYH14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.